Clinical trial
Ozurdex as Monotherapy for Treatment of Non-infectious Intermediate, Posterior, or Panuveitis
NCT05101928 is registered in ClinicalTrials.gov with Ottawa Hospital Research Institute as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Ozurdex as Monotherapy for Treatment of Non-infectious Intermediate, Posterior, or Panuveitis
- Lead sponsor
- Ottawa Hospital Research Institute
- Phase
- Phase 4
- Overall status
- Withdrawn
- Start date
- November 30, 2021
- Completion date
- January 15, 2025
- Enrollment
- 0 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.